FDA and Congress are putting forth new proposals to mitigate drug shortages, which continue to have a major impact on the US healthcare system.
Senator Susan Collins (R-ME) and Senator Tina Smith (D-MN) recently introduced the Mitigating Emergency Drug Shortages (MEDS) Act, which is garnering support from the American Society of Health-System Pharmacists and other organizations.
“We strongly support the MEDS Act as an important step toward ending drug shortages and believe that it will achieve lasting solutions, including requiring manufacturers to be transparent about causes of drug shortages and sources of active pharmaceutical ingredients, while also establishing contingency plans to maintain supplies in the event of manufacturing disruptions,” said ASHP CEO Paul W. Abramowitz, PharmD, FASHP, in a statement. “The ongoing shortages of vital, life-saving medications continue to jeopardize patient care in the United States.
“Pharmacists and other healthcare providers struggle to obtain reliable supplies of essential medications, resulting in delay or prevention of treatment, serious harm to patients, and unnecessary added costs to our healthcare system,” Abramowitz, added.
Meanwhile, FDA’s inter-agency Drug Shortages Task Force issued a report, “Drug Shortages: Root Causes and Potential Solutions,” which attempts to identify root causes and offer solutions.